Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 1,090,012 | 979,631 | 865,006 | 817,509 | 725,884 |
| Cost of Goods | 479,939 | 423,401 | 365,451 | 362,140 | 348,450 |
| Gross Profit | 610,073 | 556,230 | 499,555 | 455,369 | 377,434 |
| Operating Expenses | 502,167 | 409,198 | 361,818 | 349,174 | 322,565 |
| Operating Income | 108,845 | 147,433 | 138,188 | 106,335 | 55,319 |
| Interest Expense | 20,219 | 31,006 | 28,207 | 24,088 | 30,612 |
| Other Income | 8,701 | -1,068 | -4,763 | -17,278 | 20,736 |
| Pre-tax Income | 97,327 | 115,359 | 105,218 | 64,969 | 45,443 |
| Income Tax | 31,035 | 38,055 | 36,692 | 20,790 | 13,633 |
| Net Income Continuous | 66,292 | 77,304 | 68,526 | 44,179 | 31,810 |
| Net Income Discontinuous | 1,950 | -1,133 | -663 | N/A | N/A |
| Net Income | $68,242 | $76,171 | $67,863 | $44,179 | $31,100 |
| EPS Basic Total Ops | 2.65 | 3.00 | 2.70 | 1.79 | 1.27 |
| EPS Basic Continuous Ops | 2.58 | 3.04 | 2.73 | 1.79 | 1.30 |
| EPS Basic Discontinuous Ops | 0.07 | -0.04 | -0.03 | N/A | N/A |
| EPS Diluted Total Ops | 2.58 | 2.90 | 2.61 | 1.74 | 1.27 |
| EPS Diluted Continuous Ops | 2.51 | 2.94 | 2.63 | 1.74 | 1.30 |
| EPS Diluted Discontinuous Ops | 0.07 | -0.04 | -0.02 | N/A | N/A |
| EBITDA(a) | $108,845 | $147,433 | $138,188 | $106,335 | $55,319 |